Respiratory sequelae among children and adolescents post-tuberculosis treatment in Abuja, Nigeria
DOI:
https://doi.org/10.18203/2349-3291.ijcp20252507Keywords:
Adolescents, Post-tuberculosis lung disease, Respiratory sequelae, Spirometry, ChildrenAbstract
Background: Despite successfully completed treatment, respiratory sequelae known as post-tuberculosis (TB) lung disease (PTLD) has been reported in 1% to 49% of children and adolescents TB survivors. Post-TB lung disease has been identified as a priority research area in Africa. However, available studies have been mainly among adults in developed countries. This study aimed to determine respiratory sequelae among children and adolescents previously treated for pulmonary TB by identifying persisting respiratory symptoms and lung function assessment.
Methods: A cross-sectional study among participants who had completed TB treatment within the last five years but not less than six months post-treatment. A proformer was used to document biodata, vital signs, anthropometric measurements, TB history, persisting respiratory symptoms, spirometry and incentive spirometry test results.
Results: Seventy-one names were extracted from records, 38 participated in the study. The mean age was 11.92 years, 23 (60.5%) underweight, 24 (63.2%) had at least one symptom sequela, mostly cough 23 (60.5%) and easy fatigability 23 (60.5%). Majority, 25 (65.8%) had abnormal spirometry results and 23 (60.5%) were able to sustain 600cc of air using the incentive spirometer. There was a significant association between symptom sequelae and nutritional status (p=0.002) and between symptom sequelae and age (p=0.001). Also, between lung function and age (p value<0.001) and between lung function and nutritional status (p value =0.002).
Conclusions: Majority had post-Tb sequelae. In order to improve health-related outcomes, children and adolescents should be followed up post-TB treatment and should include pulmonary and nutritional assessments.
Metrics
References
World Health Organisation. Tuberculosis. 2025 Available at https://www.who.int/news-room/fact-sheets/detail/tuberculosis Accessed on 17 May 2025.
Federal Ministry of Health. Annual TB report. 2023 Available at: file:///C:/Users/NCC/Downloads/NTBLCP-2023. Accessed on 7 June 2025.
World Health Organisation. Tuberculosis. 2020 Available at: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed on 7 April 2025.
World Health Organisation. WHO Consolidated guidelines on tuberculosis Module 4: Treatment- Drug-susceptible tuberculosis treatment. Geneva: World Health Organization. 2022. Available at: https://iris.who.int/bitstream. Accessed on 9 May 2025
Allwood BW, Nightingale R, Agbota G, Auld S, Bisson GP, Byrne A et al. Perspectives from the 2nd international post-tuberculosis symposium: mobilising advocacy and research for improved outcomes. Int J Tuberc Lung Dis. 2024;1:111-23. DOI: https://doi.org/10.5588/ijtldopen.23.0619
Mozafarri A. Clinical manifestation and pulmonary function test after post tuberculosis treatment. Eur Respir J. 2018;52:2747. DOI: https://doi.org/10.1183/13993003.congress-2018.PA2747
Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55:32–8. DOI: https://doi.org/10.1136/thorax.55.1.32
Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011;15:886–91. DOI: https://doi.org/10.5588/ijtld.10.0526
Akkara SA, Shah AD, Adalja M, Akkara AG, Rathi A, Shah DN. Pulmonary tuberculosis: the day after. Int J Tuberc Lung Dis. 2013;17:810–3. DOI: https://doi.org/10.5588/ijtld.12.0317
Amaral AF, Coton S, Kato SB, Tan WC, Studnicka M, Janson C, et al. Tuberculosis associates with both airflow obstruction and low lung function: BOLD results. Eur Respir J. 2015;46:1104-12. DOI: https://doi.org/10.1183/13993003.02325-2014
Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015;32:138-46. DOI: https://doi.org/10.1016/j.ijid.2014.12.016
Brode SK, Daley CL, Marras TK. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis. 2014;18(11):1370-7. DOI: https://doi.org/10.5588/ijtld.14.0120
Pasqualotto AC, Denning DW. An aspergilloma caused by Aspergillus flavus. Med Mycol. 2008;46:275-8. DOI: https://doi.org/10.1080/13693780701624639
Igbokwe V, Ruby LC, Sultanli A, Bélard S. Post-tuberculosis sequelae in children and adolescents: a systematic review. Lancet Infect Dis. 2023;23:138-50. DOI: https://doi.org/10.1016/S1473-3099(23)00004-X
Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja TE, et al. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One. 2013;8:80302. DOI: https://doi.org/10.1371/journal.pone.0080302
Ranzani OT, Rodrigues LT, Bombarda S, Minto CM, Waldman EA, Carvalho CRR. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study. Lancet Infect Dis 2020;20: 123–32. DOI: https://doi.org/10.1016/S1473-3099(19)30518-3
Hoger S, Lykens S, Beavers SF, Katz D, Miller TL. Longevity loss among cured tuberculosis patients and the potential value of prevention. Int J Tuberc Lung Dis. 2014;18:1347–52. DOI: https://doi.org/10.5588/ijtld.14.0242
Osman M, Welte A, Dunbar R., Brown R, Hodinnott G, Hesseling AC et al. Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study. Int J Infect Dis. 2019;85:57-63. DOI: https://doi.org/10.1016/j.ijid.2019.05.024
Romanowski K, Baumann B, Basham AC, Khan FA, Fox GJ, Johnston JC. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Di. 2019;19:1129–37. DOI: https://doi.org/10.1016/S1473-3099(19)30309-3
Mortimer K, Nantanda R, Meghji J, Vanker A, Bush A, Ndimande N et al. Africa’s respiratory “big five”. JPATS.2021;2:64-72. DOI: https://doi.org/10.25259/JPATS_12_2021
Coates AL, Graham BL, McFadden RG, McParland C, Moosa D, Provencher S, Road J. Spirometry in Primary Care. Can Respire J. 2013;20:13–22. DOI: https://doi.org/10.1155/2013/615281
Physiopedia. Incentive Spirometry. 2025 Available at: https://www.physio-pedia.com.Spirometry Accessed on 10 May 2025.
Franklin E, Anjum F. Incentive Spirometer and Inspiratory Muscle Training. In: StatPearls. Treasure Island (FL): StatPearls Publishing LLC. 2025.
Restrepo RD, Wettstein R, Wittnebel L, Tracy M. Incentive spirometry. Respiratory Care 2011;56: 1600-1604. DOI: https://doi.org/10.4187/respcare.01471
NHS Thames Valley Haematology Network. Patient information: incentive spirometry. 2025 Available at: http://nssg.oxford-haematology.org.uk/red-cell/documents/acute-management-sickle-cell-disease/S52-how-to-use-an-incentive-spirometer.pdf Accessed on 10 March 2025.
Savci S, Sakinc ̧S, Ince ID, Arikan H, Zehr C, Buran Y, et al. Active cycle of breathing techniques and incentive spirometer in coronary artery bypass graft surgery. Fizyoterapi Rehabilitasyon. 2006;17:61-9.
Ekop E, Akor A, Oyari F. Timeliness of Bacilli Calmette-Guérin vaccination among infants in a tertiary health facility in sub-Saharan Africa. Ibom Med J. 2022;14:361-70. DOI: https://doi.org/10.61386/imj.v14i3.45
Chan JY, Stern DA, Guerra S, Wright AL, Morgan WJ, Martinez FD. Pneumonia in childhood and impaired lung function in adults: a longitudinal study. Pediatrics. 2015;13:607–16. DOI: https://doi.org/10.1542/peds.2014-3060
Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667–72. DOI: https://doi.org/10.1164/rccm.200802-309OC
Basile FW, Nabeta P, Ruhwald M, Song R. Pediatric Tuberculosis Diagnostics: Present and Future. J Pediatric Infect Dis Soc. 2022;11:85-93. DOI: https://doi.org/10.1093/jpids/piac082
The Union. Diagnosis and management of tuberculosis in children and adolescents a desk guide for primary health care workers. 2023. Available at: https://theunion.org/sites. Accessed on 10 May 2025.
Nkereuwem E, Agbla S, Njai, B, Edem VF, Jatta ML, Owolabi O, et al. Post-tuberculosis respiratory impairment in Gambian children and adolescents: a cross-sectional analysis. Pediatr Pulmonol. 2024;59:1912-21. DOI: https://doi.org/10.1002/ppul.27009
van der Zalm MM, Jongen VW, Swanepoel R, Zimri K, Allwood B, et al. Impaired lung function in adolescents with pulmonary tuberculosis during treatment and following treatment completion. eClinical Medicine. 2024;67:102406. DOI: https://doi.org/10.1016/j.eclinm.2023.102406
Nkereuwem E, Agbla S, Sallahdeen A, Owolabi O, Sillah AK, Genekah M et al. Reduced lung function and health-related quality of life after treatment for pulmonary tuberculosis in Gambian children: a cross-sectional comparative study. Thorax. 2023;78:281-7. DOI: https://doi.org/10.1136/thorax-2022-219085
Ozoh OB, Ojo OO, Dania MG, Dede SK, Adegboyega OA, Irurhe NK, et al. Impact of post tuberculosis lung disease on health-related quality of life. Afr J Thoracic Crit Care Med. 2021;27:46-52. DOI: https://doi.org/10.7196/AJTCCM.2021.v27i2.135
Manji M, Shayo G, Mamuya S, Mpembeni R, Jusabani A, Mugusi F. Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study. BMC Pulm Med. 2016;16(1):58. DOI: https://doi.org/10.1186/s12890-016-0213-5
Woldesemayat EM, Vera JH, Tanner C, Tamiso A, Assefa A, Woldesenbet YM. Lung function of tuberculosis patients after completion of treatment in Sidama, South Ethiopia. Front. Med 2025;12:1451861. DOI: https://doi.org/10.3389/fmed.2025.1451861
Ojuawo OB, Fawibe AE, Desalu OO, Ojuawo AB, Aladesanmi, AO, Opeyemi CM, et al. Spirometric abnormalities following treatment for pulmonary tuberculosis in Ilorin, Nigeria. Nigerian Postgraduate Medical J. 2020;27:163-70. DOI: https://doi.org/10.4103/npmj.npmj_18_20
Aphridassari J, Sondakh EW, Setijadi AR, Sutanto YS. Incentive spirometry and pursed lips breathing on breathlessness symptom, lung function, and quality of life in sequelae pulmonary tuberculosis. Eur Respir J. 2018;52(63):665. DOI: https://doi.org/10.1183/13993003.congress-2019.PA665
Downloads
Published
How to Cite
Issue
Section
